June 2
2026
Investors & media
multiQure is the first listed company in Poland to pursue the American biotech model. Our goal is to confirm the efficacy of our RNAi therapy in patients, and its safety profile, as quickly as possible, in order to give investors and potential partners a clear answer rather than promises.
49,99%
112850000 shares
Biofund Capital Management LLC
14,99%
33850000 shares
JD Copilot LLC
9,75%
22000000 shares
Esaliens TFI S.A.
8,86%
20000000 shares
Nationale-Nederlanden PTE S.A.
7,44%
16804603 shares
ACRX Investments Limited
8,97%
20244716 shares
Other shareholders
49,99%
112850000 votes
Biofund Capital Management LLC
14,99%
33850000 votes
JD Copilot LLC
9,75%
22000000 votes
Esaliens TFI S.A.
8,86%
20000000 votes
Nationale-Nederlanden PTE S.A.
7,44%
16804603 votes
ACRX Investments Limited
8,97%
20244716 votes
Other shareholders
Share and votes table
| Shareholder | % shares | % votes |
|---|---|---|
| Biofund Capital Management LLC | 49,99 | 49,99 |
| JD Copilot LLC | 14,99 | 14,99 |
| Esaliens TFI S.A. | 9,75 | 9,75 |
| Nationale-Nederlanden PTE S.A. | 8,86 | 8,86 |
| ACRX Investments Limited | 7,44 | 7,44 |
| Other shareholders | 8,97 | 8,97 |
Calendar of events and reports
-
RAPORT BIEŻĄCY ESPI 39/2026 – OŚWIADCZENIE KDPW W SPRAWIE ZAWARCIA Z EMITENTEM UMOWY O REJESTRACJĘ W DEPOZYCIE PAPIERÓW WARTOŚCIOWYCH AKCJI SPÓŁKI SERII R I S
-
RAPORT BIEŻĄCY ESPI 38/2026 – ZAWIADOMIENIE W TRYBIE ART. 69 USTAWY O OFERCIE PUBLICZNEJ
-
RAPORT BIEŻĄCY ESPI 37/2026 – ZAWIADOMIENIE W TRYBIE ART. 69 USTAWY O OFERCIE PUBLICZNEJ
General meetings (PL)
Corporate governance (PL)
Download
Presentations (PL)
Memoranda and prospectuses (PL)
Documents prepared in connection with the application for the introduction of financial instruments to trading conducted by the Warsaw Stock Exchange S.A.
Contact for investors
Address for submitting notifications
According to Art. 19 of the Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (MAR)